INS and Insulin resistance: In the comparison of treatment with vehicle or CDDO-Me for each group, no significant differences in body weight, adiposity index (visceral fat mass), ITT (insulin resistance), or plasma insulin, serum TG, FFA, FPG, or serum TC levels were observed (Fig 8A–8H).